Three Research Streams on Indoor CO2 and Alzheimer's Risk

Does indoor CO₂ increase Alzheimer’s risk? The calibrated answer is: no direct evidence currently links typical indoor CO₂ levels, including levels up to 2,500 ppm, to Alzheimer’s disease or long-term dementia incidence. That does not make the evidence empty. It means the evidence has to be sorted before it is used.

The search results around an “indoor co2 alzheimer risk study” look more connected than they are. One set of studies exposes people to elevated indoor CO₂ for hours and measures cognitive task performance. Another follows populations exposed to outdoor air pollution and measures dementia incidence. A third tests intermittent, very high-dose CO₂ as a possible way to move Alzheimer’s-related proteins out of the brain. Those are not three versions of the same claim.

The Indoor CO₂ Studies Are About Acute Performance, Not Dementia

The controlled indoor CO₂ studies deserve attention. They are not just “weak indoor air” anecdotes. They use defined exposures, measurable tasks, and designs that make the evidence easier to judge. If the question is whether elevated indoor CO₂ can affect short-term cognitive performance, the answer is much stronger than a vague maybe.

Satish et al. exposed 22 participants to different CO₂ levels and found 11% to 23% reductions in decision-making performance across 7 of 9 Strategic Management Simulation domains at 1,000 ppm compared with ambient levels.[1] That is a clean exam-relevant result: defined exposure, defined comparison, defined outcome. It does not say anything about amyloid plaques, tau tangles, clinical Alzheimer’s disease, or dementia diagnoses decades later.

Allen et al. sharpened the point with a double-blind crossover study of 24 participants. In green building conditions, cognitive scores were 50% lower at about 1,400 ppm CO₂ than at about 550 ppm.[2] Again, the important word is “scores.” The result matters for people taking timed exams or doing difficult analytic work in a crowded room. It does not become an Alzheimer’s risk estimate by sounding dramatic.

Fan et al. then pooled the literature in a 2023 meta-analysis of 15 studies and reported that complex task performance declines at 1,000–1,500 ppm, with effects worsened by exposure beyond 120 minutes.[3] This is the kind of finding a student can use when thinking about study rooms, testing centers, ventilation, and mental fatigue. It is also exactly the kind of finding that gets overextended when the measured outcome quietly changes from “complex task performance after a few hours” to “neurodegenerative disease risk over years.”

The Harvard Global CogFx study adds a more real-world layer. It followed 302 office workers across 6 countries using ecological momentary assessment and found cognitive effects associated with indoor air quality conditions, including CO₂-related thresholds.[4] That design is useful because people are being measured closer to ordinary work conditions. Its scores, however, are not directly interchangeable with the Strategic Management Simulation battery used in the earlier controlled studies.

For MCAT and GRE reasoning, this first stream supports a careful claim: moderately elevated indoor CO₂ can impair acute cognitive performance, particularly on complex tasks and with longer exposure. If you want practical study-environment context, that belongs with questions like how air quality affects studying on exam day, not with a diagnosis-level claim about Alzheimer’s disease.

The Dementia Evidence Is Mostly About Outdoor Pollution

The dementia evidence is larger, slower, and messier. It is also about a different exposure. A 2025 Lancet Planetary Health meta-analysis examined 51 studies with 29 million participants and reported a hazard ratio of 1.08 for incident dementia per 5 μg/m³ increase in PM2.5.[5] That is an important public-health signal. It is not a CO₂ experiment.

PM2.5 and NO₂ are not interchangeable with indoor CO₂. PM2.5 refers to fine particulate matter; NO₂ is a nitrogen dioxide exposure often related to combustion and traffic. CO₂ inside a room is often used as a ventilation proxy and can also be tested as a direct exposure in chamber studies. Swapping one exposure for another is not a small wording issue. It changes the biological question, the exposure pathway, and the study design.

The same distinction matters when reading dementia-prevention summaries. The 2024 Lancet Commission listed air pollution as a modifiable dementia risk factor, but the relevant air-pollution category is outdoor particulate and NO₂ exposure, not typical indoor CO₂ as an independent exposure.[6] A headline can compress that into “air quality affects dementia risk.” A test passage will usually punish the next, lazy step: “therefore indoor CO₂ causes Alzheimer’s.”

The 2025 meta-analysis itself does not erase uncertainty. Its evidence quality was described as moderate, with considerable heterogeneity and possible publication bias.[5] That does not make the association useless. It means the correct conclusion remains narrower: long-term exposure to certain outdoor pollutants is associated with higher incident dementia risk. The study does not test whether years spent in rooms at 1,200 or 1,800 ppm CO₂ independently increase Alzheimer’s risk.

The High-Dose CO₂ Pilot Points in a Different Direction

The most memorable study in this evidence set is also the easiest to misuse. A University of New Mexico pilot study reported that intermittent inhalation of 5% CO₂, or about 50,000 ppm, moved amyloid-beta and tau proteins from the brain into the blood during a short intervention.[7][8] The sample was small, with 12 participants, and Alzheimer’s-specific findings had been presented at AAIC 2025 while full peer-reviewed publication remained uncertain as of July 2026.[7][8]

That exposure is not a stuffy classroom. It is not a library study room with poor ventilation. It is not an office drifting above 1,000 ppm during a long meeting. It is a deliberately administered, intermittent, high-dose intervention: 35-second pulses over a 30-minute session.[7] The dose is roughly 20 times higher than 2,500 ppm and 50 times higher than 1,000 ppm.

The direction of the hypothesis is different too. The indoor CO₂ cognition studies ask whether elevated CO₂ impairs performance. The UNM pilot asks whether a sharp, controlled manipulation of blood CO₂ might stimulate a clearance mechanism. If those two claims are placed side by side without the dose and design, a reader can walk away with the absurd hybrid: CO₂ both causes Alzheimer’s and treats Alzheimer’s. The studies do not say that.

Where the Common Inference Goes Wrong

Most bad readings of this topic make one of three substitutions. Each substitution preserves the impressive part of a finding and drops the condition that made the finding valid.

• Short-term cognition becomes Alzheimer’s disease. A lower score on a complex task after CO₂ exposure is not the same outcome as Alzheimer’s pathology or incident dementia.
• Outdoor PM2.5 or NO₂ becomes indoor CO₂. Air pollutants do not become equivalent because they all appear under the phrase “air quality.”
• A 50,000 ppm intervention becomes ordinary indoor exposure. A therapeutic pulse is not evidence about chronic exposure to typical building CO₂ levels.

These are not technicalities. They are the core of evidence evaluation. On an MCAT science passage, the answer choice that changes the outcome from cognitive score to disease incidence should start to look suspicious. On a GRE argument task, the claim that borrows dementia evidence from PM2.5 studies to make a conclusion about CO₂ should read like a category error. For more practice with this kind of passage discipline, the same habit appears in topics as different as male breast cancer on the MCAT and historical analysis for GRE writing.

What a Careful Claim Can Actually Say

A careful claim does not need to pretend all uncertainty is settled. No study in this evidence set directly tests whether years of exposure to moderately elevated indoor CO₂, at levels typical of buildings and below or around 2,500 ppm, increases Alzheimer’s pathology or dementia incidence. That is a genuine evidence gap, not proof of safety and not proof of harm.

The supported conclusion is narrower and more useful: indoor CO₂ research gives good reason to care about acute cognitive performance in study and work settings; outdoor pollution research gives reason to care about dementia risk from PM2.5 and NO₂; high-dose intermittent CO₂ research gives reason to watch a possible intervention pathway. None of those streams, alone or combined, currently supports the claim that typical indoor CO₂ independently causes Alzheimer’s disease.

That is the habit worth keeping after the headline fades. When a passage gives you an impressive association, ask what was actually exposed, for how long, and what outcome was actually measured.

References

1. Is CO2 an Indoor Pollutant? Direct Effects of Low-to-Moderate CO2 Concentrations on Human Decision-Making Performance, Environmental Health Perspectives
2. Associations of Cognitive Function Scores with Carbon Dioxide, Ventilation, and Volatile Organic Compound Exposures in Office Workers, Environmental Health Perspectives
3. The effects of carbon dioxide on human cognitive performance: A systematic review and meta-analysis, Building and Environment, 2023
4. Impacts of Indoor Air Quality on Cognitive Function, Harvard Healthy Buildings, 2021
5. Air pollution and dementia: a systematic review and meta-analysis, The Lancet Planetary Health, 2025
6. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission, The Lancet, 2024
7. Inhaling high-dose CO2 clears Alzheimer’s proteins from the brain, New Scientist, July 2026
8. Researchers Study Whether Intentionally Manipulating Blood Carbon Dioxide Levels Might Enhance Brain Health, University of New Mexico Health Sciences